Clinical study of Eladi Kwath in Raktapradar.

A Single Arm Clinical Study to evaluate the efficacy of Eladi Kwath in Raktapradar w.s.r to Menorrhagia. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087491

Enrollment

Registered

2025-05-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N71- Inflammatory disease of uterus, except cervix

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with cyclic excessive per vaginal bleeding for more than 7days or quantity more than 80ml or both with or without clots during menstrual cycle Hb 10gm or more Patients with Adenomyosis Fibroid uterus less than 3cms endometriosis and pelvic inflammatory disease

Exclusion criteria

Exclusion criteria: Patients with IUCD in utero chronic tubo ovarian mass Tubercular Endometritis Granulosa cell tumor of ovary Patients with known case of Systemic disorder like hypertension liver cirrhosis Patients with known case of Hypothyroidism Hyperthyroidism leukemia thrombocytopenia DUB Suspected cases of Spontaneous threatened or incomplete abortion

Design outcomes

Primary

Measure	Time frame
To Evaluate the Efficacy of Eladi Kwath in Raktapradar.Timepoint: To Evaluate the Efficacy of Eladi Kwath in Raktapradar i.e. at baseline, 4 weeks, 8weeks & 12 weeks	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Nishigandha Pol

YMT Ayurvedic Medical College and Hospital

nishigandhabhavake@gmail.com8108150590

Outcome results